DE69407056T2 - 5-(1-fluorovinyl)-1h-pyrimidin-2,4-dion-derivate als antineoplastische mittel - Google Patents

5-(1-fluorovinyl)-1h-pyrimidin-2,4-dion-derivate als antineoplastische mittel

Info

Publication number
DE69407056T2
DE69407056T2 DE69407056T DE69407056T DE69407056T2 DE 69407056 T2 DE69407056 T2 DE 69407056T2 DE 69407056 T DE69407056 T DE 69407056T DE 69407056 T DE69407056 T DE 69407056T DE 69407056 T2 DE69407056 T2 DE 69407056T2
Authority
DE
Germany
Prior art keywords
fluorovinyl
pyrimidine
antineoplastic agent
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69407056T
Other languages
English (en)
Other versions
DE69407056D1 (en
Inventor
James Mccarthy
Donald Matthews
Jeffrey Sabol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/236,599 external-priority patent/US5512678A/en
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69407056D1 publication Critical patent/DE69407056D1/de
Publication of DE69407056T2 publication Critical patent/DE69407056T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69407056T 1993-09-14 1994-08-23 5-(1-fluorovinyl)-1h-pyrimidin-2,4-dion-derivate als antineoplastische mittel Expired - Fee Related DE69407056T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12140593A 1993-09-14 1993-09-14
US08/236,599 US5512678A (en) 1993-09-14 1994-04-29 5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
PCT/US1994/009502 WO1995007917A1 (en) 1993-09-14 1994-08-23 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents

Publications (2)

Publication Number Publication Date
DE69407056D1 DE69407056D1 (en) 1998-01-08
DE69407056T2 true DE69407056T2 (de) 1998-04-09

Family

ID=26819425

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69407056T Expired - Fee Related DE69407056T2 (de) 1993-09-14 1994-08-23 5-(1-fluorovinyl)-1h-pyrimidin-2,4-dion-derivate als antineoplastische mittel

Country Status (16)

Country Link
EP (1) EP0719271B1 (de)
JP (1) JPH09509137A (de)
CN (1) CN1042429C (de)
AT (1) ATE160571T1 (de)
AU (1) AU690579B2 (de)
CA (1) CA2170608C (de)
DE (1) DE69407056T2 (de)
DK (1) DK0719271T3 (de)
ES (1) ES2111330T3 (de)
FI (1) FI961172A (de)
GR (1) GR3026075T3 (de)
HU (1) HUT73414A (de)
IL (1) IL110919A0 (de)
NO (1) NO306348B1 (de)
NZ (1) NZ273161A (de)
WO (1) WO1995007917A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
EP0882734B1 (de) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5-Deoxy-Cytidin-Derivate
DE10313035A1 (de) * 2003-03-24 2004-10-07 Resprotect Gmbh Methode zur Verstärkung der apoptotischen Wirkung von Zytostatika ohne Erhöhung toxischer Nebenwirkungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383990A (en) * 1980-10-01 1983-05-17 Beecham Group Limited Antiviral agents, their preparation and use
US5116823A (en) * 1990-02-27 1992-05-26 Roger Williams General Hospital Drug combinations containing AZT
FR2659330B1 (fr) * 1990-03-09 1994-02-11 Sapec Sa Composes diastereoisomeres derivant de l'acide tetrahydrofolique, procede de preparation et utilisation dans la synthese de diastereomeres 6s et 6r de folates reduits.

Also Published As

Publication number Publication date
EP0719271A1 (de) 1996-07-03
HUT73414A (en) 1996-07-29
NO306348B1 (no) 1999-10-25
NZ273161A (en) 1997-11-24
FI961172A0 (fi) 1996-03-13
FI961172A (fi) 1996-03-13
DK0719271T3 (da) 1997-12-29
CA2170608A1 (en) 1995-03-23
AU690579B2 (en) 1998-04-30
CA2170608C (en) 1999-03-30
NO961027L (no) 1996-03-13
NO961027D0 (no) 1996-03-13
ES2111330T3 (es) 1998-03-01
JPH09509137A (ja) 1997-09-16
IL110919A0 (en) 1994-11-28
GR3026075T3 (en) 1998-05-29
HU9600644D0 (en) 1996-05-28
ATE160571T1 (de) 1997-12-15
DE69407056D1 (en) 1998-01-08
WO1995007917A1 (en) 1995-03-23
EP0719271B1 (de) 1997-11-26
CN1130909A (zh) 1996-09-11
AU7636394A (en) 1995-04-03
CN1042429C (zh) 1999-03-10

Similar Documents

Publication Publication Date Title
ATE275134T1 (de) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
HUP9802304A2 (hu) Piridazin-3-on-származékok, intermedierjeik, alkalmazásuk, a vegyületeket hatóanyagként tartalmazó herbicid készítmények
DE69404917D1 (de) Multiwirkstoffresistenz-umkehrende Mittel
MX9801129A (es) Agentes farmaceuticos.
NO994115L (no) Nye 1,4-diazacykloheptanderivater og deres anvendelse i haaroksydasjonsfargestoffer
DE69407056T2 (de) 5-(1-fluorovinyl)-1h-pyrimidin-2,4-dion-derivate als antineoplastische mittel
BG101601A (en) Pharmaceutical piperazine compounds
DE69910568D1 (de) Furopyridinderivate und ihre therapeutische verwendung
TR199801648T2 (xx) Herbisid olarak pirazol-4-il-hetaroil t�revleri
TR199902115T2 (xx) 2,3- Dihidrofuro (3,2-b) piridiun t�revleri, haz�rlan��lar� ve terapide uygulanmalar�.
MX9706014A (es) Derivados de xanteno y acridina y su empleo.
HUP0001010A2 (hu) Benzimidazol-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
YU78001A (sh) Derivati 6-(((aril i heteroaril)oksi)metil) naftalen-2- karboksimidamida, njihovo dobijanje i terapeutska primena
DK0596917T3 (da) Benzimidazolanthelmintika
ATE123025T1 (de) 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica.
AU603390B2 (en) 1-carbamoyl-2-pyrazoline derivatives having herbicidal activity
ATE260261T1 (de) Oligobenzimidazolderivate und ihre verwendung als dna-transfektionsmittel
KR950026862A (ko) 벤조일 우레아 유도체
DE3779099D1 (de) Substituierte phenoxypropionaldehydderivate.
TW257759B (en) Piperazine derivatives (2)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee